This new volume provides a plethora of new information about potential medicinal herbs and their usefulness in treating diabetes and neurological diseases. Most large multinational companies are interested and engaged in the commercialization of herb-based formulations, and consumers continue to seek natural-based therapies.
Herbs for Diabetes and Neurological Disease Management provides insight into plant-based novel molecules targeted for diabetes and neurological disorders. It looks at a selection of herbs that have proven effective in the management of diabetes and neurological disorders, including migraine, epilepsy, memory disorders, depression, and more. Divided into ten chapters focusing on diabetes and its macro- and microvascular complications (migraine, epilepsy, memory disorders, depression and other neuropsychiatric disorders), this book is structured to provide a source of reliable information and enrich the knowledge of readers. Each chapter briefly explains the epidemiology and pathophysiology of the disease state and thepossible role of herbal drugs in the prevention of the particular disease. The reported pharmacological activities and possible mechanism of action of herbal drugs are also discussed in detail, which makes this book informative and unique.
This new volume will be a reliable reference complementing the substantial information on the use of herbal drugs in diabetes and neurological disorders that serve as the pillars of drug discovery and development.
- offers an overview of role of St.-John’s Wort in the management of diabetes and neurological disorders
- covers the potential of natural products in the treatment of memory disorders
- details the phytoconstituents and their potential for anticonvulsant activity in established animal models of epilepsy
- explores the pivotal role of herbal drugs in neuropsychiatric illnesses
- explores the role of herbal drugs in the treatment of migraine
- considers natural products in the development of current anti-diabetic drugs
- details various herbal drugs as effective treatment options for depression
- discusses the medicinal herbs used for prevention and maintenance of diabetes and neurodegenerative diseases
Role of St.-John’s Wort (Hypericum perforatum L.) in the Management of Diabetes and Neurological Disorders
Yusuf Ozturk, Ozgur Devrim Can, and Umide Demir-Ozkay
A Potential Natural Product Combination Targeting Memory Disorders
Manju Bhaskar, Meena Chintamaneni, and Veeranjaneyulu Addepalli
Phytotherapeutic Agents in Epilepsy
Herbal Medicines in Neuropsychiatric Illness: The Case of L-Stepholidine
Nitin Sati, Kedar S. Prabhavalkar, Sridhar N., and Lokesh K. Bhatt
Potential of Curcuma longa and Withania Somnifera for Diabetes and Associated Neurological Comorbidities
Suruchi Verma, Amitabha Dey, and Vikas Kumar
Migraine: Management and Treatment with Herbal Drugs
- K. Arulmozhi, Yogesh A. Kulkarni, Addepalli Veeranjaneyulu, and R. S. Gaud
Complications of Diabetes and Role of a Citrus Flavonoid Nobiletin in Its Treatment
- K. Bhatt, N. A. Parkar, V. Addepalli, and R. S. Gaud
Diabetes and Phytopharmaceuticals: Translational Pharmacology Perspective
Priyanka Ingle-Jadhav, Trupti R. Angolkar, and Ginpreet Kaur
Natural Products as Effective Treatment Option for Depression
Yogesh A. Kulkarni, Kalyani H. Barve, and Ginpreet Kaur
Medicinal Plants Research
Mila Emerald and David Marrero
Vikas Kumar, PhD, is currently an Innovation Specialist at DD Innovations, Inc., Edina, Minnesota, USA. He was formerly Associate Professor of Pharmacology at the Neuropharmacology Research Laboratory, Department of Pharmaceutics, at theIndian Institute of Technology (Banaras Hindu University) in Uttar Pradesh, India. He has published more than 150 papers in peer-reviewed journals as well as four chapters. He has visited Canada, Germany, France, China, Nepal, Thailand,Singapore, South Africa, Italy and UAE to enhance his professional experience at various capacities. He is life member of several professional associations and serves as a member of editorial boards of many peer-reviewed international journals. He previously worked successfully and productively in the pharmaceutical industries viz. Lupin Research Park, Pune, and Indian Herbs Research & Supply Co. Ltd., Saharanpur, India. Based on his research findings, Indian Herbs Ltd. successfullylaunched a product viz. MoodOn® (as a herbal antidepressant and mood enhancer) into the Indian market in collaboration with Bergen Healthcare, a division of Alkem Laboratories Ltd., Mumbai. Currently, MoodOn® is sold under trade nameEnMood® (http://www.indianherbs.org/mEnMood.htm). He also has scientific collaborations with Dr. Willmar Schwabe GmbH & Co. KG, Germany. Dr. Kumar has received the Sami Khatib Gold Medal for being a topper in B.Pharm. and Servier Young Investigators’ Award instituted by Institutet de Researches Internationales Servier, France. He is also recipient of the coveted institutional and globally reputed Rashtriya Gaurav Award in 2011 for his achievements in the field of science and technology. Dr. Kumar has obtained his PhD degree from IIT (BHU), Varanasi in 2001 after completing MPharm and BPharm from Gulbarga University in 1997 and 1995 respectively.
Addepalli Veeranjaneyulu, PhD, is presently serving as Associate Dean and Senior Professor and Head of Pharmacology at SPP, the School of Pharmacy and Technology Management (SPTM), NMIMS, Mumbai, India. He was formerly a VisitingScientist/Professor at the International Institute of Medical Sciences in China (from 2006-07) under the auspices of Canadian Heart Foundations. Dr. Addepalli has 16 years of industrial new drug discovery research experience, with over six years as Assistant Director (Pharmacology and Quality Assurance) at NCER, at Lupin Research Park, Pune, India, and over ten years as Research Executive (Pharmacology and Pharmacokinetics) in IDPL R&D, Hyderabad, India. He has 18 years of teachingexperience. His research interests are cardiovascular dysfunction and other complications in diabetes; receptor pharmacology; serotonergic receptors; and modulatory roles in migraine, psychosis, and other CNS disorders. He was the Principal Investigator for several projects funded by CSIR, UGC, AICTE, and pharma industrial/academia collaborative projects funded by various pharma companies. He is a member of several national and international professional bodies and is an editorial board member and reviewer for several journals journals. Dr. Addepalli has over 180 research publications in national and international journals with three industrial patents to his credit. He also presented papers at international and nationalconferences and seminars and also chaired scientific sessions.